Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Optimi HealthOPTH -0.10%19 Equity-to-Asset is 0.68 as of Jun. 2026, which is 23% below its 10-year median of 0.88. GuruFocus rates OPTH with a GF Score™ of 19/100 and a GF Value™ of $2.47 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 1,006 Drug Manufacturers companies, Optimi Health ranks better than 62.23% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Optimi Health's Total Stockholders Equity for the quarter that ended in Jun. 2026 was $12.57 Mil. Optimi Health's Total Assets for the quarter that ended in Jun. 2026 was $18.43 Mil.
Therefore, Optimi Health's Equity to Asset Ratio for the quarter that ended in Jun. 2026 was 0.68.
The historical rank and industry rank for Optimi Health's Equity-to-Asset or its related term are showing as below:
OPTH'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.26 Med: 0.88 Max: 0.99
Current: 0.68
During the past 6 years, the highest Equity to Asset Ratio of Optimi Health was 0.99. The lowest was 0.26. And the median was 0.88.
OPTH's Equity-to-Asset is ranked better than 62.23% of 1006
companies
in the Drug Manufacturers industry
Industry Median: 0.6
vs OPTH: 0.68
Optimi Health (NAS:OPTH) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Optimi Health Equity-to-Asset Related Terms
Optimi Health Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Optimi Health's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Optimi Health's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Optimi Health Equity-to-Asset vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Optimi Health's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Optimi Health's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Optimi Health's Equity to Asset Ratio for the fiscal year that ended in Sep. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Optimi Health (OPTH) has a Equity-to-Asset of 0.68 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Optimi Health and its competitors. This is 23% below median its historical median of 0.88. Over the past decade, Optimi Health's Equity-to-Asset has ranged from 0.26 to 0.99. According to the industry distribution chart, Optimi Health ranks #380 out of 1006 companies in the Drug Manufacturers industry, placing it in the top 37.8%.
Is Optimi Health's Equity-to-Asset too high?
Optimi Health's current Equity-to-Asset of 0.68 is 23% below median its 10-year median of 0.88. Over the past 10 years, this metric has ranged from a low of 0.26 to a high of 0.99. The Drug Manufacturers industry median Equity-to-Asset is 0.60. Optimi Health's value of 0.68 is 13.3% above this industry median. Based on the distribution chart, Optimi Health ranks #380 out of 1006 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Optimi Health has a GF Score™ of 19/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Optimi Health's Equity-to-Asset compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Optimi Health ranks #380 out of 1006 companies for Equity-to-Asset. This puts Optimi Health in the upper half of its industry. The industry median Equity-to-Asset is 0.60. Optimi Health's value of 0.68 is 13.3% above this benchmark. Historically, Optimi Health's own Equity-to-Asset has ranged from 0.26 to 0.99 over the past decade. While the company's 10-year median is 0.88 vs. the industry median of 0.60, Optimi Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Drug Manufacturers company?
The median Equity-to-Asset among Drug Manufacturers companies is 0.60, based on 1,006 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Optimi Health's current Equity-to-Asset of 0.68 is 13.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Optimi Health and its competitors. For the Drug Manufacturers industry, the median Equity-to-Asset is 0.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Optimi Health's current Equity-to-Asset is 0.68, which is 23% below median its own 10-year median of 0.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Optimi Health stock overvalued right now?
Based on GuruFocus' analysis, Optimi Health (OPTH) is currently considered Significantly Overvalued. The stock's GF Value™ is $2.47, compared to a current price of $4.91 — trading 98.8% above its estimated fair value. The current Equity-to-Asset is 0.68, which is 23% below median its 10-year median of 0.88 and 13.3% above the Drug Manufacturers industry median of 0.60. Optimi Health's overall GF Score™ is 19/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Optimi Health (OPTH), the current Equity-to-Asset is 0.68 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Optimi Health (OPTH) Overvalued in 2026?
Based on GuruFocus' analysis, Optimi Health stock appears to be overvalued.
The current stock price of $4.91 is trading 98.8% above its estimated GF Value™ of $2.47.
GuruFocus considers Optimi Health to be Significantly Overvalued.
Key valuation signals for OPTH:
Equity-to-Asset: 0.68 (23% below median its 10-year median of 0.88)
GF Value™: $2.47 vs. price of $4.91 (98.8% above fair value)
Industry Position: 13.3% above the Drug Manufacturers median (#380 of 1006)
No single metric tells the full story. See the OPTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Optimi Health Corp operates in developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness sector. The company has one reportable operating segment being that of the farming, processing, and distribution of raw mushroom biomass. It also intends to cultivate, extract, process, and distribute strains of fungi products at its facilities located in Princeton, British Columbia.
19GF Score
Get the complete analysis for OPTH
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OPTH has been successfully added to your 
